Roca Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series A
- Investors
-
6
Roca Therapeutics General Information
Description
Developer of a biotechnology platform designed to create cancer therapies to give new life and vision to patients. The company's platform focuses on developing new anti-cancer therapeutic strategies, in particular by targeting several major players in tumor development and aggressiveness, inflammation, chronic immunosuppression, and tumor cell proliferation, enabling patients to receive a new chance at life through the treatment of rare cancers.
Contact Information
Website
www.roca-therapeutics.orgCorporate Office
- Institut Delvalle
- 27 Rue Du Professeur Delvalle
- 06000 Nice
- France
Corporate Office
- Institut Delvalle
- 27 Rue Du Professeur Delvalle
- 06000 Nice
- France
Roca Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC (Series A) | 07-Apr-2023 | Completed | Generating Revenue | |||
| 5. Seed Round | 10-May-2022 | Completed | Generating Revenue | |||
| 4. Grant | Completed | Startup | ||||
| 3. Accelerator/Incubator | Completed | Startup | ||||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. University Spin-Out | 28-Apr-2021 | Completed | Startup |
Roca Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Roca Therapeutics Signals
Roca Therapeutics Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 3B Future Health Fund | Venture Capital | Minority | ||
| SATT Sud-Est | Corporation | Minority | ||
| Université Côte d'Azur | University | |||
| Bpifrance | Sovereign Wealth Fund | |||
| Incubator Provence Côte d'Azur | Accelerator/Incubator |
Roca Therapeutics FAQs
-
When was Roca Therapeutics founded?
Roca Therapeutics was founded in 2021.
-
Where is Roca Therapeutics headquartered?
Roca Therapeutics is headquartered in Nice, France.
-
What is the size of Roca Therapeutics?
Roca Therapeutics has 8 total employees.
-
What industry is Roca Therapeutics in?
Roca Therapeutics’s primary industry is Drug Discovery.
-
Is Roca Therapeutics a private or public company?
Roca Therapeutics is a Private company.
-
What is Roca Therapeutics’s current revenue?
The current revenue for Roca Therapeutics is .
-
How much funding has Roca Therapeutics raised over time?
Roca Therapeutics has raised $1.78M.
-
Who are Roca Therapeutics’s investors?
3B Future Health Fund, SATT Sud-Est, Université Côte d'Azur, Bpifrance, and Incubator Provence Côte d'Azur are 5 of 6 investors who have invested in Roca Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process